Staidson Beijing Biopharma (300204) — Defensive Interval Ratio

Latest as of March 2026: 92 days

Staidson Beijing Biopharma (300204) has a Defensive Interval Ratio of 92 days as of March 2026. Defensive assets of CN¥33.02 Million (cash CN¥-, short-term investments CN¥-, receivables CN¥33.02 Million) cover 92 days of daily cash needs of CN¥359.18K/day. Check Staidson Beijing Biopharma tangible book value ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

92 days
Days of operational coverage

Defensive Assets

CN¥33.02 Million
Cash + ST Investments + Receivables

Daily Cash Need

CN¥359.18K
Current Liabilities ÷ 365

Current Liabilities

CN¥131.10 Million
CNY

Staidson Beijing Biopharma Defensive Interval Ratio (2007–2025)

This chart shows how Staidson Beijing Biopharma's Defensive Interval Ratio has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the ratio stands at 92 days, meaning defensive assets of CN¥33.02 Million can fund 92 days of operations without new revenue. Also explore net asset growth rate of Staidson Beijing Biopharma to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Staidson Beijing Biopharma (2007–2025)

The table below presents the year-by-year Defensive Interval Ratio for Staidson Beijing Biopharma from 2007 to 2025, covering 19 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see 300204 stock market capitalisation.

Year DIR (days) Defensive Assets (CNY) Daily Cash Need Cash ST Investments Change (days)
2025 50 days CN¥24.13 Million CN¥480.95K/day CN¥- CN¥- ▼ -44 days
2024 94 days CN¥39.72 Million CN¥423.15K/day CN¥- CN¥- ▼ -13 days
2023 107 days CN¥61.22 Million CN¥570.33K/day CN¥- CN¥- ▼ -189 days
2022 296 days CN¥188.18 Million CN¥635.00K/day CN¥- CN¥- ▼ -707 days
2021 1003 days CN¥540.53 Million CN¥538.74K/day CN¥- CN¥381.46 Million ▼ -19 days
2020 1022 days CN¥589.47 Million CN¥576.53K/day CN¥- CN¥461.24 Million ▲ +115 days
2019 908 days CN¥443.61 Million CN¥488.69K/day CN¥- CN¥275.00 Million ▼ -180 days
2018 1087 days CN¥693.18 Million CN¥637.44K/day CN¥- CN¥480.85 Million ▲ +400 days
2017 687 days CN¥655.28 Million CN¥953.78K/day CN¥- CN¥277.10 Million ▼ -268 days
2016 955 days CN¥1.04 Billion CN¥1.09 Million/day CN¥- CN¥607.86 Million ▲ +582 days
2015 373 days CN¥360.98 Million CN¥968.12K/day CN¥- CN¥- ▼ -75 days
2014 448 days CN¥316.10 Million CN¥705.97K/day CN¥- CN¥- ▲ +1 days
2013 447 days CN¥268.00 Million CN¥599.86K/day CN¥- CN¥- ▼ -52 days
2012 499 days CN¥215.34 Million CN¥431.45K/day CN¥- CN¥- ▼ -220 days
2011 719 days CN¥52.46 Million CN¥72.94K/day CN¥- CN¥- ▲ +563 days
2010 156 days CN¥11.41 Million CN¥73.03K/day CN¥- CN¥- ▼ -164 days
2009 320 days CN¥21.50 Million CN¥67.22K/day CN¥- CN¥- ▲ +92 days
2008 228 days CN¥15.46 Million CN¥67.80K/day CN¥- CN¥- ▲ +95 days
2007 133 days CN¥17.64 Million CN¥132.46K/day CN¥- CN¥- —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)